Legal Representation
Attorney
Dean G. Stathakis
USPTO Deadlines
Next Deadline
1335 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-03-28)
Due Date
March 28, 2029
Grace Period Ends
September 28, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 29, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 29, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 29, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 28, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 28, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 10, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 10, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 21, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 2, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 8, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 8, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 8, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 8, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 8, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 19, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 19, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 19, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 6, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 6, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 6, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 7, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 6, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 6, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 7, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 7, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 7, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 4, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 3, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 3, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 4, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 4, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 4, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 5, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances and veterinary pharmaceutical preparations and substances for the treatment and prevention of cancer, cardiovascular, endocrine or hormonal, gastrointestinal, inflammatory, musculoskeletal, microbial, neurodegenerative, neurological, urological conditions, diseases and disorders; antipyretic, analgesics, and anti-inflammatory medications; pain relief medications; headache treatment and migraine treatment preparations; cough, cold and fever relief medications, namely, allergy tablets, chewable tablets, cough pastilles for medical use, throat lozenges, and medicinal syrups for the treatment of cough, cold and fever, heartburn, upset stomach, acid reflex; acid indigestion relief medications; diarrhea relief medications; anti-microbial, anti-viral, and anti-bacterial medication[s] and preparations for treating microbial, viral, and bacterial infections, burn relief medications; allergy relief medications; antihistamines; acne medications
First Use Anywhere:
Aug 20, 2014
First Use in Commerce:
Aug 20, 2014
Additional Information
Pseudo Mark
IN FIRST PLUS HEALTHCARE; IN FIRST PLUS HEALTH CARE
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTHCARE"